LINDSAY DOUGHERTY: Open Payments
NPI 1669957155 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,137 in 7 payments from 4 companies in 2025. Trend: 2023 $1,570 · 2024 $3,509 · 2025 $7,137
Consulting: $7,118Food & beverage: $19
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $5,063 |
| Janssen Scientific Affairs, LLC | 1 | $1,275 |
| Janssen Global Services, LLC | 1 | $780 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: RYBREVANT, INGREZZA.
Industry payments across PA — which companies pay providers there.
